Press release - 03/03/2021 New Baden-Württemberg network to reduce animal experiments A new network has been set up in Baden-Württemberg aimed at reducing animal experiments as well as further improving animal welfare. It combines new approaches and measures at the state’s biomedical research locations, which are expected to limit stress in laboratory animals and steadily reduce the number of animals used in research in line with the 3R principles of Replacement, Reduction, and Refinement.https://biopro-v9-test-gi.xanium.io/en/article/press-release/new-baden-wuerttemberg-network-reduce-animal-experiments
Heidelberg Technology Park - 05/05/2020 Start-up support for life sciences companies How can scientists turn their know-how into marketable products and services and thereby provide society with real added value? In addition to solid financing, start-up companies need a suitable infrastructure and a dense network of partners for exchanging expertise to help them get off to a good start when it comes to setting up a business. The Heidelberg Technology Park offers company founders in the life sciences exactly these success factors.https://biopro-v9-test-gi.xanium.io/en/article/news/start-up-support-for-life-sciences-companies
Funding Erasmus for Young Entrepreneurs Scholarship, Funded by: EUhttps://biopro-v9-test-gi.xanium.io/en/database/funding/erasmus-for-young-entrepreneurs
The Baden-Württemberg healthcare industry Infrastructure https://biopro-v9-test-gi.xanium.io/en/location/infrastructure
The Baden-Württemberg healthcare industry Company foundation https://biopro-v9-test-gi.xanium.io/en/location/start-up
The Baden-Württemberg healthcare industry The biotechnology sector https://biopro-v9-test-gi.xanium.io/en/location/biotech
Dossier - 04/11/2013 Biotechnology driver of innovation in the pharmaceutical industry The biotech industry is the innovative driver for a pharmaceutical industry that, due to the shift from blockbluster products to personalised medicine, now depends on new concepts. The production of new drugs using genetic engineering relies on knowledge gained from genomics, proteomics and systems biology and creates new treatment strategies that combine therapy and diagnostics (i.e. companion diagnostics) to provide a specific individualised…https://biopro-v9-test-gi.xanium.io/en/article/dossier/biotechnology-driver-of-innovation-in-the-pharmaceutical-industry
Dossier - 10/09/2012 Horizon 2020 the EU framework programme for research and innovation a boost for top-level research in Europe In the face of the ongoing financial crisis Europe is working on a new research strategy that is aimed at creating new economic growth and jobs. The new EU framework programme for research and innovation Horizon 2020 replaces the 7th Framework Programme FP7 and will run from 2014 with a budget of 80 billion. In July 2012 Brussels launched the final FP7 calls for proposals for 2013 that offer numerous market-based instruments designed to bridge…https://biopro-v9-test-gi.xanium.io/en/article/dossier/horizon-2020-the-eu-framework-programme-for-research-and-innovation-a-boost-for-top-level-research-i
